| scholarly article | Q13442814 |
| P2093 | author name string | E. S. Huang | |
| A. D. Yurochko | |||
| T. F. Kowalik | |||
| S. M. Huong | |||
| P2860 | cites work | A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. | Q45142085 |
| An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator | Q46006922 | ||
| p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction | Q46602560 | ||
| The NF-kappa B p65 promoter. | Q48130543 | ||
| Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. | Q54753839 | ||
| Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus | Q68240850 | ||
| High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients | Q70466647 | ||
| The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulatio | Q72696029 | ||
| Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 | ||
| O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation | Q24296741 | ||
| I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding | Q24307786 | ||
| Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha | Q24318577 | ||
| Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus | Q24337591 | ||
| Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression | Q24337872 | ||
| The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B | Q24564833 | ||
| Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 | Q28245874 | ||
| Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation | Q28776205 | ||
| Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B | Q29618193 | ||
| Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal | Q29618196 | ||
| Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B | Q29618210 | ||
| The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product | Q29618249 | ||
| Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity | Q29618284 | ||
| Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity | Q30452167 | ||
| The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50 | Q33938198 | ||
| DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide | Q34088506 | ||
| Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. | Q34373627 | ||
| An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter | Q36069170 | ||
| Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection | Q36090467 | ||
| Human cytomegalovirus. III. Virus-induced DNA polymerase | Q36538365 | ||
| Human cytomegalovirus. I. Purification and characterization of viral DNA. | Q36596962 | ||
| Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins | Q36651434 | ||
| Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus | Q36653844 | ||
| Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site | Q36680389 | ||
| A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2 | Q36680417 | ||
| The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor | Q36687270 | ||
| Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2 | Q36690662 | ||
| Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation | Q36697729 | ||
| The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal | Q36701599 | ||
| Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products | Q36781657 | ||
| Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. | Q36781988 | ||
| The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site | Q36796246 | ||
| Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains | Q36803353 | ||
| Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter | Q36811230 | ||
| trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus | Q36865895 | ||
| Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter | Q36919288 | ||
| Modulation of HIV-enhancer activity by heterologous agents: a minireview | Q37765769 | ||
| Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. | Q37879797 | ||
| Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter | Q38304794 | ||
| The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator | Q38306731 | ||
| Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. | Q38316296 | ||
| Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. | Q38318544 | ||
| I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention | Q38325326 | ||
| E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection | Q38325725 | ||
| HSV-1-inducible proteins bind to NF-kappa B-like sites in the HSV-1 genome | Q38327239 | ||
| The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation | Q38333912 | ||
| Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. | Q38336043 | ||
| NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation | Q38342724 | ||
| Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. | Q40038064 | ||
| Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex. | Q40038595 | ||
| Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. | Q40041760 | ||
| The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. | Q40043548 | ||
| Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain | Q40048677 | ||
| A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in tra | Q40064469 | ||
| The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. | Q40066427 | ||
| A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins | Q40115668 | ||
| Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha | Q40401245 | ||
| The I kappa B proteins: members of a multifunctional family | Q40721710 | ||
| Increased levels of sequence-specific DNA-binding proteins in human cytomegalovirus-infected cells | Q41507865 | ||
| The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation | Q41514176 | ||
| Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. | Q41562747 | ||
| In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. | Q41576192 | ||
| The precursor of NF-kappa B p50 has I kappa B-like functions | Q41598400 | ||
| The immediate early genes of human cytomegalovirus upregulate expression of the cellular genes myc and fos | Q41606845 | ||
| GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase | Q41718635 | ||
| SV40 stimulates expression of the transacting factor Sp1 at the mRNA level | Q41738735 | ||
| The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements | Q42452064 | ||
| Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters | Q44941631 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | promoter | Q224093 |
| NF-κB | Q411114 | ||
| Cytomegalovirus | Q6946 | ||
| transcriptional activation | Q71230901 | ||
| P304 | page(s) | 5391-5400 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters | |
| P478 | volume | 69 |
| Q42717415 | 17-allylamino-17-(demethoxy)geldanamycin (17-AAG) is a potent and effective inhibitor of human cytomegalovirus replication in primary fibroblast cells |
| Q37422869 | Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter |
| Q33793056 | Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. |
| Q39652483 | An additional long-term mechanism of NF-κB regulation after cytokine treatment in a human hepatoma cell line |
| Q35703488 | Analysis of splice variants of the immediate-early 1 region of human cytomegalovirus |
| Q39403005 | Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines |
| Q47756263 | Aspirin Attenuates Cytomegalovirus Infectivity and Gene Expression Mediated by Cyclooxygenase-2 in Coronary Artery Smooth Muscle Cells |
| Q39880886 | Binding of SP1 to the immediate-early protein-responsive element of the human cytomegalovirus DNA polymerase promoter |
| Q33925240 | Biphasic regulation of A20 gene expression during human cytomegalovirus infection |
| Q84549550 | Cellular signals involved in cyclooxygenase-2 expression induced by human cytomegalovirus |
| Q39686042 | Characterization of a Human Cytomegalovirus with Phosphorylation Site Mutations in the Immediate-Early 2 Protein |
| Q39448135 | Cytomegalovirus IE2 protein stimulates interleukin 1beta gene transcription via tethering to Spi-1/PU.1. |
| Q38717606 | Cytomegalovirus and Mucoepidermoid carcinoma: A possible causal relationship? A pilot study |
| Q42144694 | Cytomegalovirus and Tumors: Two Players for One Goal-Immune Escape |
| Q33326039 | Cytomegalovirus induces abnormal chondrogenesis and osteogenesis during embryonic mandibular development |
| Q36517563 | Cytomegalovirus inhibition of embryonic mouse tooth development: a model of the human amelogenesis imperfecta phenocopy |
| Q28534550 | Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor |
| Q92263929 | Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis |
| Q33256757 | Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model |
| Q40444834 | Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus |
| Q74290868 | Dual regulatory role of human cytomegalovirus immediate-early protein in IL1B transcription is dependent upon Spi-1/PU.1. |
| Q33643399 | Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: studies with ts13 cells |
| Q37683123 | Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway |
| Q33957986 | Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway |
| Q39593607 | Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. |
| Q39582163 | Extracellular Signal-Regulated Kinase Activity Is Sustained Early during Human Cytomegalovirus Infection |
| Q89977247 | Factors in Oncogenesis: Viral Infections in Ovarian Cancer |
| Q38339684 | Functional Interference of Sp1 and NF-κB through the Same DNA Binding Site |
| Q58582955 | HCMV miRNA Targets Reveal Important Cellular Pathways for Viral Replication, Latency, and Reactivation |
| Q33900418 | Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation. |
| Q39913109 | Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity |
| Q40475356 | High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. |
| Q51813836 | Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation |
| Q40303671 | Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ. |
| Q35140023 | Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV |
| Q33886711 | Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ |
| Q37451979 | Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein |
| Q39291106 | Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression |
| Q36161015 | Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells |
| Q34858442 | Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. |
| Q42424904 | Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation |
| Q40468638 | Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. |
| Q34683482 | Human cytomegalovirus immediate early proteins and cell growth control |
| Q47548990 | Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival |
| Q37361231 | Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells |
| Q37422612 | Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence |
| Q36232248 | Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination |
| Q34589568 | Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients |
| Q42378308 | Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells |
| Q34336521 | Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3'-OH kinase pathway and the cellular kinase Akt. |
| Q49195425 | Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: A quantitative and histological analysis |
| Q40584504 | Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. |
| Q33842473 | Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling |
| Q35789277 | Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha |
| Q46723963 | Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action |
| Q33782285 | Identification of Positive and Negative Regulatory Regions Involved in Regulating Expression of the Human Cytomegalovirus UL94 Late Promoter: Role of IE2-86 and Cellular p53 in Mediating Negative Regulatory Function |
| Q54256751 | Identification of diverse defense mechanisms in rainbow trout red blood cells in response to halted replication of VHS virus. |
| Q91260126 | Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer |
| Q40624760 | Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells |
| Q39879958 | Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters |
| Q39512381 | Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. |
| Q35940905 | Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells |
| Q34055763 | Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation |
| Q34648184 | Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. |
| Q54597465 | Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha |
| Q37060045 | Interactions between Human Cytomegalovirus IE1-72 and Cellular p107: Functional Domains and Mechanisms of Up-Regulation of Cyclin E/cdk2 Kinase Activity |
| Q41112980 | Intracellular thiol redox status affects rat cytomegalovirus infection of vascular cells |
| Q37805181 | Is HCMV a tumor promoter? |
| Q45659478 | Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization |
| Q46405136 | Mechanisms of viral infections associated with HIV: workshop 2B. |
| Q57009346 | Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus |
| Q39753137 | Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities |
| Q35786286 | Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice |
| Q28344246 | Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication |
| Q41955869 | Murine cytomegalovirus virion-associated protein M45 mediates rapid NF-κB activation after infection |
| Q33557568 | NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha |
| Q36944091 | Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro |
| Q37948126 | OX40:OX40L axis: emerging targets for improving poxvirus‐based CD8+ T‐cell vaccines against respiratory viruses |
| Q40480154 | Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta. |
| Q33784945 | Phosphorylation of the Human Cytomegalovirus 86-Kilodalton Immediate-Early Protein IE2 |
| Q52641505 | Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin. |
| Q28193489 | Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression |
| Q35846755 | Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice |
| Q35943427 | RNA Interference-Mediated Targeting of Human Cytomegalovirus Immediate-Early or Early Gene Products Inhibits Viral Replication with Differential Effects on Cellular Functions |
| Q92221569 | RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer |
| Q33781921 | Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Liver: Involvement of NFκB |
| Q34364116 | RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members |
| Q41885111 | Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. |
| Q35551066 | Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation |
| Q78549918 | Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer |
| Q40303024 | Stimulation of interferon-beta gene expression by human cytomegalovirus via nuclear factor kappa B and phosphatidylinositol 3-kinase pathway |
| Q34856545 | Strain variations in single amino acids of the 86-kilodalton human cytomegalovirus major immediate-early protein (IE2) affect its functional and biochemical properties: implications of dynamic protein conformation |
| Q34749766 | Synergism between HIV and other viruses in the mouth |
| Q24802610 | Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma |
| Q35894831 | TAF-like functions of human cytomegalovirus immediate-early proteins |
| Q24300688 | The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism |
| Q37177231 | The chemokine receptor homologue encoded by US27 of human cytomegalovirus is heavily glycosylated and is present in infected human foreskin fibroblasts and enveloped virus particles |
| Q39462585 | The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling |
| Q91866555 | The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications |
| Q35872328 | The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. |
| Q34594875 | The human cytomegalovirus UL26 protein antagonizes NF-κB activation |
| Q35887796 | The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection |
| Q35857513 | The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha |
| Q35143349 | The human cytomegalovirus. |
| Q33716504 | The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early protein IE2/IEP86 affects temporal viral gene expression |
| Q37395985 | The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus |
| Q33781947 | Transcription Factor Sp1 Mediates Cell-Specific trans -Activation of the Human Cytomegalovirus DNA Polymerase Gene Promoter by Immediate-Early Protein IE86 in Glioblastoma U373MG Cells |
| Q36884194 | Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on. |
| Q33908697 | Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication |
| Q90167808 | UL26 Attenuates IKKβ-Mediated Induction of Interferon-Stimulated Gene (ISG) Expression and Enhanced Protein ISGylation during Human Cytomegalovirus Infection |
| Q35665805 | Varicella-Zoster Virus Inhibition of the NF-κB Pathway during Infection of Human Dendritic Cells: Role for Open Reading Frame 61 as a Modulator of NF-κB Activity |
| Q24315863 | ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65 |
Search more.